Quipt Home Medical Corp.·4

Mar 16, 9:44 AM ET

Greenberg Mark Alan 4

Research Summary

AI-generated summary

Updated

Quipt (QIPT) Director Mark Alan Greenberg Sells 435,457 Shares

What Happened

  • Mark Alan Greenberg, a director of Quipt Home Medical Corp. (QIPT), disposed of 435,457 common shares to the issuer at $3.65 per share for proceeds of $1,589,418 on March 16, 2026.
  • The Form 4 also reports dispositions of 428,750 and 60,000 shares as derivative security transactions (no per-share price listed on the report). Footnotes explain these derivative holdings (options and RSUs) were settled or forfeited as part of a corporate arrangement.

Key Details

  • Transaction date: 2026-03-16; cash consideration for common shares: $3.65/share.
  • Reported cash proceeds (for the 435,457 shares): $1,589,418.
  • Derivative items: 428,750 and 60,000 shares reported as disposed (derivative); footnote F2 states 92,862 RSUs were forfeited immediately prior to the effective time.
  • Footnote F1: Purchasers acquired all outstanding shares under a court-approved plan of arrangement; each non-dissenting share converted into the right to receive US$3.65 in cash.
  • Footnote F3: Outstanding options were deemed vested and surrendered for cash equal to the excess of $3.65 over the option exercise price (options with exercise price ≥ $3.65 were cancelled for no consideration).
  • Shares owned after the transaction: not specified in the filing.
  • Filing date/Period of Report: 2026-03-16 (same day as the transaction), indicating a timely filing.

Context

  • These dispositions were part of a corporate buyout/arrangement that cash‑settled shareholders and certain equity awards at $3.65/share — not open‑market trading.
  • Derivative transactions reflect cash settlements of options and forfeiture/termination of RSUs per the arrangement; such settlements are administrative results of the deal rather than routine insider market trades.